Johnson & Johnson company profile

JNJ · NYSE · USD

Compare Johnson & Johnson
$278.70Change from previous close: −1.36%Absolute change: −$3.85

Close · November 17, 2026

Company profile

Johnson & Johnson has 138,200 employees and is headquartered in New Brunswick, United States.

Sales are split between the United States, which generated 57.1% of revenue, and markets outside the US, which generated 42.9%. Johnson & Johnson researches, manufactures and sells healthcare products through two segments. Innovative Medicine supplies prescription drugs for oncology, immunology and neuroscience, as well as cardiovascular and metabolic conditions, pulmonary hypertension and infectious diseases, through retailers, wholesalers, hospitals and healthcare professionals. The MedTech segment serves surgeons, physicians, nurses and eye care professionals with orthopedic, spine, cardiovascular and surgical products, including robotic systems, stapling devices and wound closure, as well as breast aesthetics and reconstruction products, contact lenses under the ACUVUE brand and intraocular lenses under the TECNIS brand.

In the fiscal year ended December 2025, revenue reached USD 94.2 billion, up 6.0% from the previous year, and net income was USD 26.8 billion. The group had 138,200 employees and is headquartered in New Brunswick, New Jersey, where it was founded in 1886.

Company facts

Industry
Drug Manufacturers - General
Headquarters
One Johnson & Johnson Plaza, 08933, New Brunswick
Employees
138,200
Chief executive
Joaquin Duato
Founded
1886
Fiscal year
January - December
Listing
JNJ · NYSE
Currency
USD
ISIN
US4781601046
Website
jnj.com

Johnson & Johnson and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Johnson & JohnsonJNJUnited States$680.19B138,20026.6%42.9
AbbVieABBVUnited States$517.59B57,00036.6%50.4
Eli LillyLLYUnited States$1.28T50,00051.3%46.5
Merck & Co.MRKUnited States$356.13B73,00035.2%144.5
AmgenAMGNUnited States$250.07B31,50034.1%26.8
Gilead SciencesGILDUnited States$211.18B17,00038.2%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Johnson & Johnson with its competitors